(Q33667372)

28 July 2017

1 reference

title

Myb targeted therapeutics for the treatment of human malignancies (English)

1 reference

28 July 2017

Gewirtz AM

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

18

1 reference

28 July 2017

issue

19

1 reference

28 July 2017

page(s)

3056-3062

1 reference

An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Viral myb oncogene encodes a sequence-specific DNA-binding activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Mechanism of c-myc regulation by c-Myb in different cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Triplex-mediated, in vitro targeting of psoralen photoadducts within the genome of a transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Biologic and therapeutic significance of MYB expression in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Functional knock-out of c-myb by an intracellular anti-c-Myb single-chain antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

The homeobox gene GBX2, a target of the myb oncogene, mediates autocrine growth and monocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

The role of Myb proteins in normal and neoplastic cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Binding of c-Myb to the core sequence of the CD4 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Isolation of human cDNA clones of myb-related genes, A-myb and B-myb

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the myb oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Role of the KIT protooncogene in normal and malignant human hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Colocalizing ribozymes with substrate RNAs to increase their efficacy as gene inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

A dominant interfering Myb mutant causes apoptosis in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Truncated c-Myb expression in the human leukemia cell line TK-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Constitutively expressed c-myb abrogates the requirement for insulinlike growth factor 1 in 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

The carboxyterminus of human c-myb protein stimulates activated transcription in trans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Antisense technology and prospects for therapy of viral infections and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

A comparison of the effect of bcr/abl breakpoint specific phosphothiorate oligodeoxynucleotides on colony formation by bcr/abl positive and negative, CD34 enriched mononuclear cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Leukemogenesis: Small differences in Myb have large effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

Local delivery of c-myb antisense oligonucleotides during balloon angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

7 January 2021

Relationship between the c-myb locus and the 6q-chromosomal aberration in leukemias and lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

7 January 2021

Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

7 January 2021

Effect of bcr-abl oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

7 January 2021

The hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

7 January 2021

G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

7 January 2021

A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

7 January 2021

Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-myb

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

7 January 2021

c-myb affects intracellular calcium handling in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202785

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1202785

1 reference

Dimensions Publication ID

28 July 2017

1047698576

0 references

1 reference